Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
Questinol
Cat. No.:
OB0425LY-334
Appearance:
Solid
Purity:
≥95%
Identity:
Confirmed by NMR.
Size:
Add to basket
Product Overview
Description:
Questinol is a palmitic acid with anti-obesity and anti-cancer properties. It is isolated from Talaromyces stipitatus.
Synonyms:
35688-09-6; 1,6-Dihydroxy-3-(hydroxymethyl)-8-methoxyanthracene-9,10-dione; 1,6-Dihydroxy-3-(hydroxymethyl)-8-methoxy-9,10-anthracenedione; 9,10-Anthracenedione, 1,6-dihydroxy-3-(hydroxymethyl)-8-methoxy-
CAS No.:
35688-09-6
Compound CID:
147621
Formula:
C16H12O6
Formula Weight:
300.26
Specification
Source:
Talaromyces stipitatus
Target:
Others
Pathway:
Others
Storage:
Storage at -20°C.
Applications:
Questinol can be used to inhibit cell proliferation and induce apoptosis in various cancer lines.
